Coeptis Therapeutics Holdings, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 21.27 million compared to USD 37.57 million a year ago. Basic loss per share from continuing operations was USD 0.83 compared to USD 2.63 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3348 USD | +3.98% | +1.15% | -57.29% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-57.29% | 12.08M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- COEP Stock
- News Coeptis Therapeutics Holdings, Inc.
- Coeptis Therapeutics Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023